What You Need to Know: Ligand, AVEO, and Pfizer (AVEO, LGND, PFE)

What You Need to Know: Ligand, AVEO, and Pfizer

In this video, Motley Fool health care analyst David Williamson takes us through some of the biggest investing stories in the health care space yesterday. He tells us about Ligand's (Nasdaq: LGND ) big FDA win -- and why its relevance may be very short-lived -- and how AVEO Pharmaceuticals (Nasdaq: AVEO ) is bouncing back after taking a big hit last week and what's ahead for the company. He also discusses how pharmaceutical giant Pfizer (NYSE: PFE ) doesn't always get what it wants.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.